USAID Funding Cuts Could Trigger 14 Million Deaths by 2030
USAID funding cuts could cause 14m avoidable deaths by 2030, including 4.5m children under five, warns Lancet study.
New COVID-19 Variant No Threat to South Africa
While the COVID-19 pandemic has subsided from its peak, the virus continues to circulate globally. SA experts demand vaccine access.
Substandard Cancer Drugs in Africa Are A Serious Concern
An alarming investigation has revealed the prevalence of substandard cancer drugs in Africa, putting patients at risk with ineffective treatments.
Biovac Secures Deal to Produce Pneumonia Vaccine
Biovac secures a deal with Biological E to produce a pneumonia vaccine in Africa, promoting vaccine independence continent-wide.
Fears of Disease Outbreaks as Global Child Vaccination Rates Stall
Global childhood immunisation is faltering due to inequality, COVID-19, and misinformation, a new study in The Lancet warns. Millions of children are now at risk from preventable diseases like measles, threatening decades of public health progress. Researchers have issued a stark new warning. Global efforts to vaccinate children against deadly diseases are faltering, putting millions…...
Zimbabwe flu outbreak mimics COVID-19
The Zimbabwean Deputy Minister of Health and Child Care, Sleiman Kwidini, has sought to calm growing public anxiety over a nationwide flu outbreak. This flu exhibits symptoms strikingly similar to those of COVID-19. Consequently, there are concerns about a potential Zimbabwe flu outbreak. Kwidini confirmed that while a significant wave of influenza is affecting many…...
Ghana’s Diabetes Crisis: A Public Health Emergency
Understand Ghana's diabetes crisis, where 2.4 million people face daily challenges due to inadequate health infrastructure.
National Health Insurance (NHI) and Political Criticism
Is National Health Insurance (NHI) a solution or a trap? Discover the criticism and concerns raised against this healthcare initiative.
Twice-Yearly HIV Jab: Activists Call for Lower Prices
Explore the revolutionary Twice-Yearly HIV Jab, a potential game-changer in HIV prevention that raises important affordability questions.
HIV Prevention Strategies with Lenacapavir Injection
In a decision that could fundamentally reshape the fight against HIV, the US Food and Drug Administration (FDA) has given its approval to Gilead Sciences’ lenacapavir, a groundbreaking twice-yearly injection for preventing HIV infection in adults and adolescents. Marketed under the brand name Yeztugo in the US, this innovative drug has been eagerly anticipated by…...